Healthcare provider profile · identity verified

Javier V Batista

Family Practice · HIALEAH, FL · NPI 1386678886

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	504	178
Losartan Potassium	Losartan Potassium	283	98
Metformin Hcl	Metformin Hcl	234	82
Levothyroxine Sodium	Levothyroxine Sodium	219	70
Lisinopril	Lisinopril	178	63
Amlodipine Besylate	Amlodipine Besylate	168	61
Gabapentin	Gabapentin	167	46
Pantoprazole Sodium	Pantoprazole Sodium	164	57
Xarelto	Rivaroxaban	151	19
Hydrochlorothiazide	Hydrochlorothiazide	141	44
Unifine Pentips	Pen Needle, Diabetic	122	19
Temazepam	Temazepam	118	17
Alendronate Sodium	Alendronate Sodium	112	36
Sildenafil Citrate	Sildenafil Citrate	107	27
Metoprolol Tartrate	Metoprolol Tartrate	98	30
Simvastatin	Simvastatin	90	30
Rosuvastatin Calcium	Rosuvastatin Calcium	89	34
Glipizide	Glipizide	86	30
Insulin Aspart Flexpen	Insulin Aspart	78	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	74	19
Metoprolol Succinate	Metoprolol Succinate	72	24
Alprazolam	Alprazolam	71	14
Tamsulosin Hcl	Tamsulosin Hcl	70	25
Escitalopram Oxalate	Escitalopram Oxalate	66	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	17
Carvedilol	Carvedilol	62	17
Furosemide	Furosemide	60	21
Memantine Hcl	Memantine Hcl	60	16
Famotidine	Famotidine	58	17
Clonazepam	Clonazepam	56	suppressed
Omeprazole	Omeprazole	55	18
Oxybutynin Chloride Er	Oxybutynin Chloride	53	13
Latanoprost	Latanoprost	47	11
Benzonatate	Benzonatate	45	36
Hydralazine Hcl	Hydralazine Hcl	43	12
Clopidogrel	Clopidogrel Bisulfate	41	17
Nifedipine Er	Nifedipine	41	15
Ozempic	Semaglutide	41	suppressed
Eliquis	Apixaban	40	suppressed
Meloxicam	Meloxicam	40	32
Donepezil Hcl	Donepezil Hcl	39	suppressed
Tradjenta	Linagliptin	39	suppressed
Sertraline Hcl	Sertraline Hcl	37	13
Allopurinol	Allopurinol	36	11
Azithromycin	Azithromycin	33	28
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	26
Finasteride	Finasteride	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Trazodone Hcl	Trazodone Hcl	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Valsartan	Valsartan	26	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Glimepiride	Glimepiride	25	11
Lactulose	Lactulose	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Atenolol	Atenolol	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	19
Lorazepam	Lorazepam	22	suppressed
Dutasteride	Dutasteride	21	suppressed
Ammonium Lactate	Ammonium Lactate	20	11
Divalproex Sodium	Divalproex Sodium	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Ibuprofen	Ibuprofen	19	15
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Folic Acid	Folic Acid	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Naproxen	Naproxen	14	11
Baclofen	Baclofen	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	11
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error